BDTX
Price
$1.98
Change
+$0.02 (+1.02%)
Updated
Sep 11 closing price
Capitalization
113.76M
58 days until earnings call
Intraday BUY SELL Signals
REPL
Price
$12.92
Change
-$0.32 (-2.42%)
Updated
Sep 11 closing price
Capitalization
1.22B
47 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BDTX vs REPL

BDTX vs REPL Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
BDTX vs. REPL commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BDTX is a Hold and REPL is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
REPL($1.22B) has a higher market cap than BDTX($114M). REPL YTD gains are higher at: 32.922 vs. BDTX (-18.519). BDTX has higher annual earnings (EBITDA): -44.35M vs. REPL (-284.22M). REPL has more cash in the bank: 195M vs. BDTX (111M). BDTX has less debt than REPL: BDTX (17M) vs REPL (112M). BDTX (0) and REPL (0) have equivalent revenues.
BDTXREPLBDTX / REPL
Capitalization114M1.22B9%
EBITDA-44.35M-284.22M16%
Gain YTD-18.51932.922-56%
P/E Ratio7.33N/A-
Revenue00-
Total Cash111M195M57%
Total Debt17M112M15%
FUNDAMENTALS RATINGS
BDTX vs REPL: Fundamental Ratings
BDTX
REPL
OUTLOOK RATING
1..100
8060
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
54
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9799
PRICE GROWTH RATING
1..100
6035
P/E GROWTH RATING
1..100
99100
SEASONALITY SCORE
1..100
1143

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

REPL's Valuation (54) in the Biotechnology industry is in the same range as BDTX (58) in the null industry. This means that REPL’s stock grew similarly to BDTX’s over the last 12 months.

REPL's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as BDTX (100) in the null industry. This means that REPL’s stock grew similarly to BDTX’s over the last 12 months.

BDTX's SMR Rating (97) in the null industry is in the same range as REPL (99) in the Biotechnology industry. This means that BDTX’s stock grew similarly to REPL’s over the last 12 months.

REPL's Price Growth Rating (35) in the Biotechnology industry is in the same range as BDTX (60) in the null industry. This means that REPL’s stock grew similarly to BDTX’s over the last 12 months.

BDTX's P/E Growth Rating (99) in the null industry is in the same range as REPL (100) in the Biotechnology industry. This means that BDTX’s stock grew similarly to REPL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BDTXREPL
RSI
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
81%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 18 days ago
82%
Bullish Trend 11 days ago
76%
Declines
ODDS (%)
Bearish Trend 12 days ago
89%
Bearish Trend 2 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
75%
Aroon
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
81%
COMPARISON
Comparison
Sep 12, 2026
Stock price -- (BDTX: $1.98 vs. REPL: $12.92)
Brand notoriety: BDTX and REPL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BDTX: 88% vs. REPL: 83%
Market capitalization -- BDTX: $113.76M vs. REPL: $1.22B
BDTX [@Biotechnology] is valued at $113.76M. REPL’s [@Biotechnology] market capitalization is $1.22B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.64B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BDTX’s FA Score shows that 0 FA rating(s) are green while REPL’s FA Score has 0 green FA rating(s).

  • BDTX’s FA Score: 0 green, 5 red.
  • REPL’s FA Score: 0 green, 5 red.
According to our system of comparison, REPL is a better buy in the long-term than BDTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BDTX’s TA Score shows that 6 TA indicator(s) are bullish while REPL’s TA Score has 5 bullish TA indicator(s).

  • BDTX’s TA Score: 6 bullish, 4 bearish.
  • REPL’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, BDTX is a better buy in the short-term than REPL.

Price Growth

BDTX (@Biotechnology) experienced а -6.60% price change this week, while REPL (@Biotechnology) price change was -14.10% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.09%. For the same industry, the average monthly price growth was -3.45%, and the average quarterly price growth was +2531.70%.

Reported Earning Dates

BDTX is expected to report earnings on Nov 09, 2026.

REPL is expected to report earnings on Oct 29, 2026.

Industries' Descriptions

@Biotechnology (-6.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
BDTX
Daily Signal:
Gain/Loss:
REPL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DCCCX27.960.09
+0.32%
Nomura Small Cap Core C
VMCIX87.98N/A
N/A
Vanguard MStar Mid Cap Index Instl
IBALX37.42N/A
N/A
Transamerica Multi-Managed Balanced A
JCVWX22.87N/A
N/A
JHancock Classic Value R6
RGIVX16.16N/A
N/A
ClearBridge Global Infrastructure Inc I

REPL and

Correlation & Price change

A.I.dvisor indicates that over the last year, REPL has been loosely correlated with IMNN. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if REPL jumps, then IMNN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To REPL
1D Price
Change %
REPL100%
-2.42%
IMNN - REPL
57%
Loosely correlated
+1.38%
SNDX - REPL
49%
Loosely correlated
-3.40%
KYMR - REPL
45%
Loosely correlated
-1.74%
NRIX - REPL
43%
Loosely correlated
-2.75%
ZYME - REPL
42%
Loosely correlated
-0.74%
More